Rhoads ANN D
SEC-identified person · CIK 1250252 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Quidelortho Corp QDEL | Director | filed 2022–2026 |
| Globus Medical INC GMED | Director | filed 2012–2026 |
| Repare Therapeutics Inc. RPTX | Director | filed 2020–2026 |
| Iteos Therapeutics, Inc. ITOS | Director | filed 2020–2025 |
| Quidel Corp /DE/ QDEL | Director | filed 2020–2022 |
| Evoke Pharma Inc EVOK | Director | filed 2013–2021 |
| Forty Seven, Inc. FTSV | Chief Financial Officer | filed 2018–2020 |
| Iridex Corp IRIX | Director | filed 2017–2018 |
| Zogenix, INC. ZGNX | EVP, CFO, Treasurer & Sec. | filed 2010–2016 |
| Novellus Systems INC nvls | Director | filed 2006–2012 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.